<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biol Sport</journal-id><journal-id journal-id-type="iso-abbrev">Biol Sport</journal-id><journal-id journal-id-type="publisher-id">JBS</journal-id><journal-title-group><journal-title>Biology of sport</journal-title></journal-title-group><issn pub-type="ppub">0860-021X</issn><issn pub-type="epub">2083-1862</issn><publisher><publisher-name>Institute of Sport in Warsaw</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24744468</article-id><article-id pub-id-type="pmc">3944556</article-id><article-id pub-id-type="publisher-id">1029824</article-id><article-id pub-id-type="doi">10.5604/20831862.1029824</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>INFLUENCE OF A LOW-DOSE COX-2 INHIBITOR DRUG ON EXERCISE-INDUCED INFLAMMATION, MUSCLE DAMAGE AND LIPID PEROXIDATION</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Khoshkhahesh</surname><given-names>F.</given-names></name><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Siahkuhain</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Fisher</surname><given-names>G.</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Nakhostin-Roohi</surname><given-names>B.</given-names></name><xref ref-type="aff" rid="AF0001">1</xref></contrib></contrib-group><aff id="AF0001"><label>1</label>Department of Exercise Physiology, Ardabil Branch, Islamic Azad University, Iran</aff><aff id="AF0002"><label>2</label>Department of Exercise Physiology, University of Mohaghegh-Ardabili, Iran</aff><aff id="AF0003"><label>3</label>Department of Nutrition Sciences University of Alabama at Birmingham, Birmingham, AL, USA</aff><author-notes><corresp id="cor1">Reprint request to: <bold>Babak Nakhostin-Roohi</bold>, Ardabil Branch-Islamic Azad University, Department of Exercise Physiology, Po.B: 56135-587; Ardabil; Iran. Phone: 00984515519980, Fax: 00984517726827. E-mail: <email xlink:href="b.nakhostinroohi@arums.ac.ir">b.nakhostinroohi@arums.ac.ir</email></corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>1</month><year>2013</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2013</year></pub-date><volume>30</volume><issue>1</issue><fpage>61</fpage><lpage>65</lpage><history><date date-type="accepted"><day>09</day><month>7</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9; Biology of Sport 2013</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The purpose of this study was to examine the effect of acute low-dose celecoxib administration on exercise-induced inflammation, muscle damage and lipid peroxidation. Twenty healthy untrained males (age: 25.5&#x000b1;4.5 yrs, weight: 72.7&#x000b1;7.9 kg, height: 177.3&#x000b1;7.2 cm) were randomly assigned to treatment (T) or placebo (P) groups. Blood samples were obtained before, immediately after, 3 h after and 24 h after exercise. Subjects ran for 30 min at 75% <inline-formula id="IFD1"><mml:math id="ILM1"><mml:mover><mml:mtext>V</mml:mtext><mml:mo>.</mml:mo></mml:mover></mml:math></inline-formula>O<sub>2</sub> max on a treadmill. Participants consumed 100 mg celecoxib or a placebo immediately after and 12 h after the immediately post-exercise blood sample. Total leukocytes, neutrophils, creatine kinase (CK), C-reactive protein (CRP) and malondialdehyde (MDA) were assessed at each time point. Significant increases in total leukocytes and neutrophils were observed 3 h after exercise in both groups (P &#x0003c; 0.05). CK and CRP levels were significantly increased immediately, 3 h and 24 h after exercise in both groups (P &#x0003c; 0.05). A significant increase in MDA was observed immediately after exercise in both groups (P &#x0003c; 0.05); however, no significant group differences were observed for MDA or CK. These findings suggest that inhibition of cyclo-oxygenase activity with low-dose celecoxib does not affect exercise-induced inflammation, muscle damage, or lipid peroxidation.</p></abstract><kwd-group><kwd>celecoxib</kwd><kwd>inflammation</kwd><kwd>muscle damage</kwd><kwd>lipid peroxidation</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S0001"><title>INTRODUCTION</title><p>Routine exercise training of moderate intensity is known to enhance immune function [<xref rid="CIT0027" ref-type="bibr">27</xref>] and reduce risk of mortality [<xref rid="CIT0011" ref-type="bibr">11</xref>, <xref rid="CIT0023" ref-type="bibr">23</xref>], cardiovascular diseases, obesity, and type 2 diabetes [<xref rid="CIT0017" ref-type="bibr">17</xref>]. However, an acute bout of prolonged (&#x0003e;1.5 h) and/or strenuous exercise (55-75% maximal O<sub>2</sub> uptake) has also been shown to provoke muscle damage/soreness [<xref rid="CIT0004" ref-type="bibr">4</xref>], and elicit an acute inflammatory [<xref rid="CIT0015" ref-type="bibr">15</xref>], oxidative stress [<xref rid="CIT0007" ref-type="bibr">7</xref>, <xref rid="CIT0009" ref-type="bibr">9</xref>], and immunosuppressive response [<xref rid="CIT0025" ref-type="bibr">25</xref>] during the post-exercise recovery period. In order to alleviate these potential adverse responses following prolonged/strenuous exercise, the consumption of non-steroidal anti-inflammatory drugs (NSAIDs) has been strategically used to reduce soreness, muscle damage, and inflammation following exercise [<xref rid="CIT0013" ref-type="bibr">13</xref>].</p><p>The original NSAIDs (e.g. ibuprofen) inhibited both the constitutive cyclooxygenase (COX)-1 and the more inducible COX-2 enzyme, which both catalyze the generation of prostanoids [prostaglandins (PGE2 and PGF2a), prostacyclins and thromboxanes]; which are involved in numerous inflammatory, anaphylactic, and cardiovascular physiological processes [<xref rid="CIT0014" ref-type="bibr">14</xref>]. However, it has been postulated that COX-2 is the key enzyme which regulates the amount and duration of inflammatory cell accumulation [<xref rid="CIT0029" ref-type="bibr">29</xref>] and lipid peroxidation [<xref rid="CIT0001" ref-type="bibr">1</xref>] following exercise-induced muscle damage. Therefore, it seems plausible that the more recently developed selective COX-2 inhibitors may be more appropriate and specific to reduce excessive inflammatory reactions following exercise than the non-selective (COX-1 and COX-2) inhibitors [<xref rid="CIT0028" ref-type="bibr">28</xref>].</p><p>Celecoxib, a sulfonamide, is a selective COX-2 inhibitor that has anti-inflammatory and analgesic effects comparable to non selective NSAIDs, and presents with significantly less gastrointestinal toxicity [<xref rid="CIT0028" ref-type="bibr">28</xref>]. To date, several studies have demonstrated a lack of efficacy of NSAIDs treatment on muscle inflammation after exercise [<xref rid="CIT0012" ref-type="bibr">12</xref>, <xref rid="CIT0018" ref-type="bibr">18</xref>, <xref rid="CIT0026" ref-type="bibr">26</xref>], while others have reported enhanced recovery and reduction of inflammatory markers following exercise [<xref rid="CIT0008" ref-type="bibr">8</xref>]. Therefore, given the equivocal results regarding the effect of non-selective anti-inflammatory drugs on exercise-induced inflammation, muscle damage, and lipid peroxidation, this study was designed to investigate the influence of an acute low dose of the selective COX-2 inhibitor celecoxib on inflammation, muscle damage, and lipid peroxidation following an intense bout of aerobic exercise.</p></sec><sec sec-type="materials|methods" id="S0002"><title>MATERIALS AND METHODS</title><sec id="S20003"><title>Participants</title><p>Twenty untrained male volunteers took part in this study. All subjects were informed verbally and in writing about the nature and demands of the study, and subsequently completed a health history questionnaire. Qualifying volunteers were provided with and asked to sign an institutionally approved informed consent form. In addition to meeting the health criteria, individuals engaging in the following were also excluded from the study: smoking, alcohol intake, vitamin supplementation (e.g., vitamin A, C and E) or NSAIDs. Three-day diet records were used to estimate subjects&#x02019; average daily intake of vitamin A, C, and E prior to the beginning of the study. All subjects were untrained and had no known allergies to NSAIDs. Subjects were randomly assigned to treatment (T) (100 mg celecoxib) or placebo (P) groups. Each group was matched for height, weight, BMI, % fat and cardiovascular fitness (no significant group differences) (<xref ref-type="table" rid="T0001">Table 1</xref>). The protocol of the study was approved by the university ethics committee in accordance with the Helsinki Declaration.
</p><table-wrap id="T0001" position="float"><label>TABLE 1</label><caption><p>SUBJECTS&#x02019; CHARACTERISTICS IN TREATMENT (T) AND PLACEBO (P) GROUPS (N = 10)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">VO<sub>2</sub>max (ml&#x000b7;kg<sup>-1</sup>&#x000b7;min<sup>-1</sup>)</th><th align="center" rowspan="1" colspan="1">BMI (kg&#x000b7;m<sup>-2</sup>)</th><th align="center" rowspan="1" colspan="1">Height (cm)</th><th align="center" rowspan="1" colspan="1">Body mass (kg)</th><th align="center" rowspan="1" colspan="1">Age (yrs)</th><th align="center" rowspan="1" colspan="1">Skin folds (mm)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">34.5 &#x000b1; 2.8</td><td align="center" rowspan="1" colspan="1">23.3 &#x000b1; 2.7</td><td align="center" rowspan="1" colspan="1">176.6 &#x000b1; 7.7</td><td align="center" rowspan="1" colspan="1">72.4 &#x000b1; 8.6</td><td align="center" rowspan="1" colspan="1">25.7 &#x000b1; 3.9</td><td align="center" rowspan="1" colspan="1">45.1 &#x000b1; 6.4</td></tr><tr><td align="left" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">35.0 &#x000b1; 5.2</td><td align="center" rowspan="1" colspan="1">23.0 &#x000b1; 1.1</td><td align="center" rowspan="1" colspan="1">178.2 &#x000b1; 6.8</td><td align="center" rowspan="1" colspan="1">73.1 &#x000b1; 5.7</td><td align="center" rowspan="1" colspan="1">25.3 &#x000b1; 5.2</td><td align="center" rowspan="1" colspan="1">40.2 &#x000b1; 8.4</td></tr></tbody></table><table-wrap-foot><fn><p>Note: Data represent mean &#x000b1; SD.</p></fn></table-wrap-foot></table-wrap></sec><sec id="S20004"><title>Dietary records</title><p>Subjects were asked to keep a dietary record of their food intake 3 days prior to the exercise test session. Total daily Vitamin A, C, and E intake during the 3 days prior to testing were determined using the Dietary Manager Computer program (Food process-2). Dietary analysis revealed no statistically significant differences in vitamin A, C, and E intake between groups (<xref ref-type="table" rid="T0002">Table 2</xref>).
</p><table-wrap id="T0002" position="float"><label>TABLE 2</label><caption><p>MEAN TOTAL DIETARY INTAKE OF VITAMIN A, C, AND E OF SUBJECTS IN TREATMENT (T) AND PLACEBO (P) GROUPS</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">group T</th><th align="center" rowspan="1" colspan="1">group P</th><th align="center" rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Vitamin A (RE)</td><td align="center" rowspan="1" colspan="1">529.4 &#x000b1; 384.3</td><td align="center" rowspan="1" colspan="1">570.1 &#x000b1; 320.2</td><td align="center" rowspan="1" colspan="1">0.58</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin C (mg)</td><td align="center" rowspan="1" colspan="1">61.6 &#x000b1; 26.3</td><td align="center" rowspan="1" colspan="1">45.9 &#x000b1; 21.7</td><td align="center" rowspan="1" colspan="1">0.21</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin E (mg)</td><td align="center" rowspan="1" colspan="1">4.4 &#x000b1; 2.6</td><td align="center" rowspan="1" colspan="1">3.4 &#x000b1; 1.7</td><td align="center" rowspan="1" colspan="1">0.41</td></tr></tbody></table><table-wrap-foot><fn><p>Note: Data represent mean &#x000b1; SD.</p></fn></table-wrap-foot></table-wrap></sec><sec id="S20005"><title>Preliminary testing</title><p>Cardiovascular fitness was determined by performing a maximal oxygen uptake test (<inline-formula id="IFD2"><mml:math id="ILM2"><mml:mover><mml:mtext>V</mml:mtext><mml:mo>.</mml:mo></mml:mover></mml:math></inline-formula>O<sub>2</sub>max test). <inline-formula id="IFD3"><mml:math id="ILM3"><mml:mover><mml:mtext>V</mml:mtext><mml:mo>.</mml:mo></mml:mover></mml:math></inline-formula>O<sub>2</sub>max was measured indirectly on a treadmill using the Bruce protocol. Briefly, subjects warmed up for 4 minutes at a speed of 3 mph on a 2.5% grade. Following warm-up, subjects ran on a treadmill beginning at a moderate pace; every 3 minutes the grade and intensity were increased until exhaustion [<xref rid="CIT0003" ref-type="bibr">3</xref>]. Heart rate was monitored by a Polar Vantage XL heart rate monitor (Polar Beat, Port Washington, NY, USA). This was conducted at least 2 weeks prior to the scheduled exercise session.</p></sec><sec id="S20006"><title>Experimental design and procedures</title><p>On the morning of the trial, subjects arrived at the laboratory. They were instructed to have a standard breakfast consisting of two boiled eggs 2 h prior to the test. All subjects were required to avoid any strenuous exercise for 72 h prior to participation in the study. Participants performed a 10-min warm-up consisting of running at 50% <inline-formula id="IFD4"><mml:math id="ILM4"><mml:mover><mml:mtext>V</mml:mtext><mml:mo>.</mml:mo></mml:mover></mml:math></inline-formula>O<sub>2</sub> max (5 min) and stretching (5 min). Following the warm-up and light stretching, participants ran on a treadmill for 30 min at 75% <inline-formula id="IFD5"><mml:math id="ILM5"><mml:mover><mml:mtext>V</mml:mtext><mml:mo>.</mml:mo></mml:mover></mml:math></inline-formula> O<sub>2</sub> max. Blood samples were taken from an antecubital forearm vein before exercise, immediately after, 3 h after, and 24 h after exercise. Each sample was taken following 15 min of standing in a resting position (except for the post-exercise sample, which was taken immediately upon cessation of exercise). Subjects consumed 100 mg of celecoxib or placebo immediately following exercise and 12 h after exercise.</p></sec><sec id="S20007"><title>Blood sampling and analysis</title><p>Approximately 6 ml of whole blood was withdrawn at each time point. 1.5 ml from each sample was added to tubes containing ethylenediaminetetra-acetic acid (EDTA) for determination of leukocyte differentials using a cell counter (K-1000 Sysmax, Japan). Haemoglobin and haematocrit concentrations from whole blood samples were used to estimate plasma volume shifts. All post-exercise samples were corrected for plasma volume change according to the methods of Dill and Costill [<xref rid="CIT0005" ref-type="bibr">5</xref>]. 4.5 ml of the blood was allowed to clot at 37.5&#x000b0;C, and centrifuged at 5,000 g for 30 min. Serum was prepared according to standard methods. Serum creatine kinase (CK) was determined using commercially available methods (Roche Hittachi-911 Chemistry Autoanalizer, Germany and Japan). Serum CRP was measured by a nephelometric procedure using commercially available kits (Minineph, ZK044. L.R, Birmingham, UK). For malondialdehyde (MDA) measurement, 0.05 ml serum was added to 0.25 ml of 0.1M TCA and 0.7 ml distilled water, vortexed in a 1.5 ml centrifuge tube for 10 s, centrifuged at 4500 g for 5 min and used for high performance liquid chromatography (HPLC) (Jasco, Japan) analysis [<xref rid="CIT0010" ref-type="bibr">10</xref>].</p></sec><sec id="S20008"><title>Statistical analysis</title><p>All data are expressed as means &#x000b1; SD. A two (groups) x four (time) analysis of variance (ANOVAs) with repeated measures on time was used to compare group, time, and group x time interactions for each variable. Significant interactions were further explored using a Bonferroni correction analysis. The significance level for this study was set at P &#x0003c; 0.05 for all tests.</p></sec></sec><sec sec-type="results" id="S0009"><title>RESULTS</title><sec id="S20010"><title>Effect of exercise on markers of inflammation</title><p>Leukocyte, neutrophil, monocyte and lymphocyte counts, and CRP concentrations before, immediately after, 3 h after, and 24 h after exercise are shown in <xref ref-type="table" rid="T0003">Table 3</xref>. Total leukocyte and neutrophil counts were significantly increased 3 h after exercise in both groups and returned to pre-exercise values 24 h after exercise (P &#x0003c; 0.05). Lymphocyte counts decreased significantly 3 h after exercise in both groups (P &#x0003c; 0.05). There were no significant changes in monocyte counts in either group (P &#x0003e; 0.05). Serum CRP concentration increased significantly immediately after exercise and remained elevated for 24 h after exercise in both groups (P &#x0003c; 0.05). However, no significant changes were found for total leukocyte, neutrophil, monocyte and lymphocyte counts, or CRP concentration between groups (P &#x0003e; 0.05).
</p><table-wrap id="T0003" position="float"><label>TABLE 3</label><caption><p>TOTAL LEUKOCYTE, NEUTROPHIL AND MONOCYTE COUNT</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Parameters</th><th align="center" rowspan="1" colspan="1">Groups</th><th align="center" rowspan="1" colspan="1">Pre</th><th align="center" rowspan="1" colspan="1">Post</th><th align="center" rowspan="1" colspan="1">3h</th><th align="center" rowspan="1" colspan="1">24h</th></tr></thead><tbody><tr><td align="left" rowspan="2" valign="middle" colspan="1">Total leukocyte count (n&#x000b7;L<sup>-1</sup>)</td><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">6528 &#x000b1; 993.1</td><td align="center" rowspan="1" colspan="1">7154 &#x000b1; 1219.4</td><td align="center" rowspan="1" colspan="1">9720 &#x000b1; 1353.5<xref ref-type="table-fn" rid="TF0001">*</xref>
</td><td align="center" rowspan="1" colspan="1">6321 &#x000b1; 1088.3</td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">7071 &#x000b1; 1003.2</td><td align="center" rowspan="1" colspan="1">7594 &#x000b1; 1640.9</td><td align="center" rowspan="1" colspan="1">9167 &#x000b1; 1780.9<xref ref-type="table-fn" rid="TF0001">*</xref>
</td><td align="center" rowspan="1" colspan="1">6648 &#x000b1; 1442.5</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="2" valign="middle" colspan="1">Blood neutrophil count (n&#x000b7;L<sup>-1</sup>)</td><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">3540 &#x000b1; 734.9</td><td align="center" rowspan="1" colspan="1">4161 &#x000b1; 841.2</td><td align="center" rowspan="1" colspan="1">6660 &#x000b1; 1492.7<xref ref-type="table-fn" rid="TF0001">*</xref>
</td><td align="center" rowspan="1" colspan="1">3386 &#x000b1;775.2</td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">3798 &#x000b1;951.3</td><td align="center" rowspan="1" colspan="1">4249 &#x000b1; 1407.6</td><td align="center" rowspan="1" colspan="1">5935 &#x000b1; 1605.5<xref ref-type="table-fn" rid="TF0001">*</xref>
</td><td align="center" rowspan="1" colspan="1">3669 &#x000b1; 971.7</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="2" valign="middle" colspan="1">Blood monocyte count (n&#x000b7;L<sup>-1</sup>)</td><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">394 &#x000b1; 102.3</td><td align="center" rowspan="1" colspan="1">460 &#x000b1; 100.0</td><td align="center" rowspan="1" colspan="1">527 &#x000b1; 81.65</td><td align="center" rowspan="1" colspan="1">385 &#x000b1; 104.9</td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">467 &#x000b1; 128.3</td><td align="center" rowspan="1" colspan="1">459 &#x000b1; 114.4</td><td align="center" rowspan="1" colspan="1">545 &#x000b1; 130.3</td><td align="center" rowspan="1" colspan="1">464 &#x000b1; 156.8</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="2" valign="middle" colspan="1">Blood lymphocyte count (n&#x000b7;L<sup>-1</sup>)</td><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">2266 &#x000b1; 589.2</td><td align="center" rowspan="1" colspan="1">2220 &#x000b1; 631.2</td><td align="center" rowspan="1" colspan="1">2252 &#x000b1; 478.8<xref ref-type="table-fn" rid="TF0002">&#x02020;</xref>
</td><td align="center" rowspan="1" colspan="1">2200 &#x000b1; 567.5</td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">2441 &#x000b1; 401.9</td><td align="center" rowspan="1" colspan="1">2525 &#x000b1; 687.1</td><td align="center" rowspan="1" colspan="1">2401 &#x000b1; 646.3<xref ref-type="table-fn" rid="TF0001">&#x02020;</xref>
</td><td align="center" rowspan="1" colspan="1">2167 &#x000b1; 615.3</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="2" valign="middle" colspan="1">CRP (mg&#x000b7;L<sup>-1</sup>)</td><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">2.0 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">2.68 &#x000b1; 0.68<xref ref-type="table-fn" rid="TF0001">*</xref>
</td><td align="center" rowspan="1" colspan="1">3.31 &#x000b1; 1.03<xref ref-type="table-fn" rid="TF0001">*</xref>
</td><td align="center" rowspan="1" colspan="1">4.19 &#x000b1; 1.0<xref ref-type="table-fn" rid="TF0001">*</xref>
</td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">1.96 &#x000b1; 0.6</td><td align="center" rowspan="1" colspan="1">2.51 &#x000b1; 0.4<xref ref-type="table-fn" rid="TF0001">*</xref>
</td><td align="center" rowspan="1" colspan="1">3.12 &#x000b1; 0.6<xref ref-type="table-fn" rid="TF0001">*</xref>
</td><td align="center" rowspan="1" colspan="1">4.17 &#x000b1; 1.2<xref ref-type="table-fn" rid="TF0001">*</xref>
</td></tr></tbody></table><table-wrap-foot><fn><p>Note: Data represent mean &#x000b1; SD.</p></fn><fn id="TF0001"><label>*</label><p>Indicates significant difference from pre-exercise in both groups (P &#x0003c; 0.05).</p></fn><fn id="TF0002"><label>&#x02020;</label><p>Indicates decrease of lymphocytes compared with pre-exercise in both groups (P &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap><p>Markers of Muscle Damage and Oxidative Stress Following Exercise:</p><p>Serum CK activity were significantly increased immediately after, 3 h after, and 24 h after exercise in both groups (P &#x0003c; 0.05) (<xref ref-type="fig" rid="F0001">Figure 1</xref>). Serum MDA concentrations were significantly elevated immediately after exercise in both groups (P &#x0003c; 0.05) (<xref ref-type="fig" rid="F0002">Figure 2</xref>). However, there were no significant differences in CK or MDA concentration between groups (P &#x0003e; 0.05) (<xref ref-type="fig" rid="F0001">Figures 1</xref> and <xref ref-type="fig" rid="F0002">2</xref>).</p><fig id="F0001" position="float"><label>FIG. 1</label><caption><p>SERUM CK ACTIVITY BEFORE AND AFTER EXERCISE</p><p>Note: * Indicates significant increase compared with pre-exercise in both groups (P &#x0003c; 0.05). Values represent means &#x000b1; SD (n = 10). P: placebo, T: treatment.</p></caption><graphic xlink:href="JBS-30-1029824-g001"/></fig><fig id="F0002" position="float"><label>FIG. 2</label><caption><p>SERUM MDA CONCENTRATION BEFORE AND AFTER EXERCISE</p><p>Note: * Indicates significant increase compared with pre-exercise in both groups (P &#x0003c; 0.05). Values represent means &#x000b1; SD (n = 10). P: placebo, T: treatment.</p></caption><graphic xlink:href="JBS-30-1029824-g002"/></fig></sec></sec><sec sec-type="discussion" id="S0010"><title>DISCUSSION</title><p>The purpose of this study was to assess the effect of acute low-dose celecoxib administration on exercise-induced inflammation, muscle damage and lipid peroxidation markers following intensive aerobic exercise. To date, the efficacy of NSAIDs treatment on muscle damage, inflammation, and lipid peroxidation remains unclear. The equivocal results between studies, some demonstrating no effect [<xref rid="CIT0012" ref-type="bibr">12</xref>, <xref rid="CIT0018" ref-type="bibr">18</xref>, <xref rid="CIT0026" ref-type="bibr">26</xref>], and others reporting a reduction in inflammatory markers following exercise [<xref rid="CIT0008" ref-type="bibr">8</xref>], make it difficult to determine if NSAIDs provide protection against exercise-induced muscle damage and inflammation. In the present study, we used a selective COX-2 inhibitor and found no significant differences in all inflammatory markers between groups and each time period. These findings suggest that post-exercise administration of celecoxib does not prevent or alleviate exercise-induced inflammation.</p><p>There are several possible explanations for the lack of efficacy of celecoxib administration on inflammation markers in the present study compared with other studies: Celecoxib is a single-action NSAID blocking the COX-2 pathway and has no effect on COX-1 and lipoxygenase (LIPOX) pathways of arachidonic acid (AA) metabolism. Therefore, it has been proposed that celecoxib may not prevent the delayed COX-1 or the LIPOX induced inflammation and drift of AA metabolism towards this pathway, leading to muscle damage and inflammation [<xref rid="CIT0022" ref-type="bibr">22</xref>]. Secondly, a typical sign of acute inflammation is an increase in total leukocyte count, which occurs within a few hours after muscle damage [<xref rid="CIT0027" ref-type="bibr">27</xref>]. Evidence suggests that the inflammatory response following exercise is distinctly different from those accompanying infection or tissue injury [<xref rid="CIT0016" ref-type="bibr">16</xref>]. Therefore, physical exercise can be regarded as a prototype of physical stress which induces a pattern of hormonal and immunological responses that is similar to, yet distinctly different from, clinical physical stressors (e.g. surgery, trauma and sepsis). Finally, it is also possible that the concentration of celecoxib at the site of the injury in this study was insufficient to have caused a significant anti-inflammatory effect following the exercise protocol.</p><p>In the present study, CK activity, an indirect qualitative index of muscle damage, was significantly elevated immediately after, 3 h after, and 24 h after exercise in both groups. There was no significant difference between the two groups, which suggests a lack of efficacy of celecoxib administration on CK induced from exercise. In agreement with the present study, Hasson et al. [<xref rid="CIT0008" ref-type="bibr">8</xref>] and Donnelly et al. [<xref rid="CIT0006" ref-type="bibr">6</xref>] reported that NSAIDs had no effect on CK levels following exercise. In contrast, Pizza et al. [<xref rid="CIT0019" ref-type="bibr">19</xref>] and Tokmakidis et al. [<xref rid="CIT0026" ref-type="bibr">26</xref>] found significantly lower post-exercise CK concentration in individuals consuming NSAIDs. These discrepant findings between studies highlight the need for further research to understand the underlying physiological mechanisms between NSAID consumption and exerciseinduced muscle damage. Future work should incorporate rigorously controlled dietary and NSAID intake prior to and following exercise; this would enable better comparisons between studies.</p><p>It has been well documented that both prolonged and intense exercise cause a marked rise in oxidative stress biomarkers [<xref rid="CIT0007" ref-type="bibr">7</xref>, <xref rid="CIT0021" ref-type="bibr">21</xref>]. Potential sources of elevated reactive oxygen species (ROS) during exercise include mitochondria, NADPH oxidases, and xanthine oxidases derived from both skeletal muscle and phagocytic cells [<xref rid="CIT0020" ref-type="bibr">20</xref>]. Similar to the aforementioned studies, we demonstrated a significant increase in circulating MDA immediately after exercise. We predicted that celecoxib administration would diminish both the immune and oxidative stress response; however, this did not occur. Current exercise and non-exercise data have not provided a clear explanation regarding the efficacy of both selective COX-2 and non-selective COX-2 inhibitors for preventing or attenuating oxidative stress [<xref rid="CIT0012" ref-type="bibr">12</xref>]. Exercise and non-exercise studies have shown the ability of the nonselective COX-2 inhibitor aspirin (acetylsalicylic acid) to reduce the post-exercise oxidative stress response, decrease vascular (O<sub>2</sub>
<sup>-</sup>.) production, and attenuate angiotensin II-induced oxidative stress [<xref rid="CIT0024" ref-type="bibr">24</xref>], whereas selective COX-2 inhibition has been shown to attenuate oxidative stress in the non-exercise setting but not following exercise [<xref rid="CIT0012" ref-type="bibr">12</xref>, <xref rid="CIT0013" ref-type="bibr">13</xref>]. In fact, McAnulty et al. demonstrated an increased post-exercise oxidative stress response following NSAID intake compared to controls [<xref rid="CIT0012" ref-type="bibr">12</xref>, <xref rid="CIT0013" ref-type="bibr">13</xref>]. While the potential mechanisms remain to be determined, it has been hypothesized that NSAID use along with strenuous exercise may actually increase gut permeability and enhance endotoxin leakage from the gut into the blood, resulting in inflammation and oxidative stress [<xref rid="CIT0002" ref-type="bibr">2</xref>]. Given the equivocal findings regarding selective and non-selective COX-2 inhibition on exerciseinduced inflammation and oxidative stress, it is premature to decide whether NSAIDs should be used during exercise as a therapy to combat the inflammatory and oxidative stress response to exercise. Further research should be performed to provide a mechanistic explanation as to why results differ between studies.</p></sec><sec sec-type="conclusions" id="S0011"><title>CONCLUSIONS</title><p>In conclusion, our results indicate that celecoxib use following exercise does not alleviate inflammation, muscle damage, or oxidative stress. The relationship between selective and non-selective COX-2 inhibitors and muscle damage, inflammation, and oxidative stress should be further explored in future studies.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors wish to thank the Ardabil University of Medical Sciences for their support.</p></ack><ref-list><title>REFERENCES</title><ref id="CIT0001"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajith</surname><given-names>T</given-names></name><name><surname>Subin</surname><given-names>J.P</given-names></name><name><surname>Jacob</surname><given-names>J</given-names></name><name><surname>Sanjay</surname><given-names>P.S</given-names></name><name><surname>Babitha</surname><given-names>N.V</given-names></name></person-group><article-title>Antimutagenic and anti-oxidant activities of the non-steroidal anti-inflammatory drug celecoxib</article-title><source>Clin. Exp. Pharmacol. Physiol.</source><year>2005</year><volume>32</volume><fpage>893</fpage><lpage>888</lpage></element-citation></ref><ref id="CIT0002"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosenberg</surname><given-names>A.T</given-names></name><name><surname>Brock-Utne</surname><given-names>J.G</given-names></name><name><surname>Gaffin</surname><given-names>S.L</given-names></name><name><surname>Wells</surname><given-names>M.T</given-names></name><name><surname>Blake</surname><given-names>G.T</given-names></name></person-group><article-title>Strenuous exercise causes systemic endotoxemia</article-title><source>J. Appl. Physiol.</source><year>1988</year><volume>65</volume><fpage>106</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">3403455</pub-id></element-citation></ref><ref id="CIT0003"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruce</surname><given-names>R.A</given-names></name><name><surname>Kusumi</surname><given-names>F</given-names></name><name><surname>Hosmer</surname><given-names>D</given-names></name></person-group><article-title>Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease</article-title><source>Am. Heart J.</source><year>1973</year><volume>85</volume><fpage>546</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">4632004</pub-id></element-citation></ref><ref id="CIT0004"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarkson</surname><given-names>P.M</given-names></name><name><surname>Hubal</surname><given-names>M.J</given-names></name></person-group><article-title>Exerciseinduced muscle damage in humans</article-title><source>Am. J. Phys. Med. Rehabil.</source><year>2002</year><volume>81</volume><issue>Suppl.</issue><fpage>S52</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">12409811</pub-id></element-citation></ref><ref id="CIT0005"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dill</surname><given-names>D.B</given-names></name><name><surname>Costill</surname><given-names>D.L</given-names></name></person-group><article-title>Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration</article-title><source>J. Appl. Physiol.</source><year>1974</year><volume>37</volume><fpage>247</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">4850854</pub-id></element-citation></ref><ref id="CIT0006"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donnelly</surname><given-names>A.E</given-names></name><name><surname>Maughan</surname><given-names>R.J</given-names></name><name><surname>Whiting</surname><given-names>P.H</given-names></name></person-group><article-title>Effects of ibuprofen on exercise-induced muscle soreness and indices of muscle damage</article-title><source>Br. J. Sports Med.</source><year>1990</year><volume>24</volume><fpage>91</fpage><lpage>195</lpage></element-citation></ref><ref id="CIT0007"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>G</given-names></name><name><surname>Schwartz</surname><given-names>D.D</given-names></name><name><surname>Quindry</surname><given-names>J</given-names></name><name><surname>Barberio</surname><given-names>M.D</given-names></name><name><surname>Foster</surname><given-names>E.B</given-names></name><name><surname>Jones</surname><given-names>K.W</given-names></name><name><surname>Pascoe</surname><given-names>D.D</given-names></name></person-group><article-title>Lymphocyte enzymatic antioxidant responses to oxidative stress following high-intensity interval exercise</article-title><source>J. Appl. Physiol.</source><year>2011</year><volume>110</volume><fpage>730</fpage><lpage>737</lpage><pub-id pub-id-type="pmid">21127208</pub-id></element-citation></ref><ref id="CIT0008"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasson</surname><given-names>S.M</given-names></name><name><surname>Daniels</surname><given-names>J.C</given-names></name><name><surname>Divine</surname><given-names>J.G</given-names></name><name><surname>Niebuhr</surname><given-names>B.R</given-names></name><name><surname>Richmond</surname><given-names>S</given-names></name><name><surname>Stein</surname><given-names>P.G</given-names></name><name><surname>Williams</surname><given-names>J.H</given-names></name></person-group><article-title>Effect of ibuprofen use on muscle soreness, damage, and performance: a preliminary investigation</article-title><source>Med. Sci. Sports. Exerc.</source><year>1993</year><volume>25</volume><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">8423760</pub-id></element-citation></ref><ref id="CIT0009"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>L.L</given-names></name></person-group><article-title>Exercise and oxidative stress: role of the cellular antioxidant systems</article-title><source>Exerc. Sport Sci. Rev.</source><year>1995</year><volume>23</volume><fpage>135</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">7556349</pub-id></element-citation></ref><ref id="CIT0010"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karatas</surname><given-names>F</given-names></name><name><surname>Karatepe</surname><given-names>M</given-names></name><name><surname>Baysar</surname><given-names>A</given-names></name></person-group><article-title>Determination of free malondialdehyde in human serum by high-performance liquid chromatography</article-title><source>Anal. Biochem.</source><year>2002</year><volume>311</volume><fpage>76</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">12441155</pub-id></element-citation></ref><ref id="CIT0011"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Sui</surname><given-names>X</given-names></name><name><surname>Laditka</surname><given-names>J.N</given-names></name><name><surname>Church</surname><given-names>T.S</given-names></name><name><surname>Colabianchi</surname><given-names>N</given-names></name><name><surname>Hussey</surname><given-names>J</given-names></name><name><surname>Blair</surname><given-names>S.N</given-names></name></person-group><article-title>Cardiorespiratory Fitness as a Predictor of Dementia Mortality in Men and Women</article-title><source>Med. Sci. Sports Exerc.</source><year>2011</year><volume>44</volume><fpage>253</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21796048</pub-id></element-citation></ref><ref id="CIT0012"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAnulty</surname><given-names>S</given-names></name><name><surname>McAnulty</surname><given-names>L</given-names></name><name><surname>Nieman</surname><given-names>D</given-names></name><name><surname>Morrow</surname><given-names>J</given-names></name><name><surname>Dumke</surname><given-names>C</given-names></name><name><surname>Henson</surname><given-names>D</given-names></name></person-group><article-title>Effect of NSAID on muscle injury and oxidative stress</article-title><source>Int. J. Sports Med.</source><year>2007</year><volume>28</volume><fpage>915</fpage><lpage>909</lpage></element-citation></ref><ref id="CIT0013"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAnulty</surname><given-names>S.R</given-names></name><name><surname>Owens</surname><given-names>J.T</given-names></name><name><surname>McAnulty</surname><given-names>L.S</given-names></name><name><surname>Nieman</surname><given-names>D.C</given-names></name><name><surname>Morrow</surname><given-names>J.D</given-names></name><name><surname>Dumke</surname><given-names>C. L</given-names></name><name><surname>Milne</surname><given-names>G.L</given-names></name></person-group><article-title>Ibuprofen use during extreme exercise: effects on oxidative stress and PGE2</article-title><source>Med. Sci. Sports Exerc.</source><year>2007</year><volume>39</volume><fpage>1075</fpage><lpage>1079</lpage><pub-id pub-id-type="pmid">17596774</pub-id></element-citation></ref><ref id="CIT0014"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>S.B</given-names></name></person-group><article-title>Prostaglandins in health and disease: an overview. Semin</article-title><source>Arthritis Rheum.</source><year>2006</year><volume>36</volume><fpage>37</fpage><lpage>49</lpage></element-citation></ref><ref id="CIT0015"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>D.C</given-names></name><name><surname>Konrad</surname><given-names>M</given-names></name><name><surname>Henson</surname><given-names>D.A</given-names></name><name><surname>Kennerly</surname><given-names>K</given-names></name><name><surname>Shanely</surname><given-names>R.A</given-names></name><name><surname>Wallner- Liebmann</surname><given-names>S.J</given-names></name></person-group><article-title>Variance in the Acute Inflammatory Response to Prolonged Cycling Is Linked to Exercise Intensity</article-title><source>J. Interferon Cytokine Res.</source><year>2011</year><volume>32</volume><fpage>12</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21916608</pub-id></element-citation></ref><ref id="CIT0016"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nosaka</surname><given-names>K</given-names></name><name><surname>Clarkson</surname><given-names>P.M</given-names></name></person-group><article-title>Variability in serum creatine kinase response after eccentric exercise of the elbow flexors</article-title><source>Int. J. Sports Med.</source><year>1996</year><volume>17</volume><fpage>120</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">8833714</pub-id></element-citation></ref><ref id="CIT0017"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>B.K</given-names></name></person-group><article-title>The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control</article-title><source>Essays Biochem.</source><year>2006</year><volume>42</volume><fpage>105</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">17144883</pub-id></element-citation></ref><ref id="CIT0018"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>J.M</given-names></name><name><surname>Trappe</surname><given-names>T.A</given-names></name><name><surname>Mylona</surname><given-names>E</given-names></name><name><surname>White</surname><given-names>F</given-names></name><name><surname>Lambert</surname><given-names>C.P</given-names></name><name><surname>Evans</surname><given-names>W.J</given-names></name><name><surname>Pizza</surname><given-names>F.X</given-names></name></person-group><article-title>Ibuprofen and acetaminophen: effect on muscle inflammation after eccentric exercise</article-title><source>Med. Sci. Sports Exerc.</source><year>2003</year><volume>35</volume><fpage>892</fpage><lpage>896</lpage><pub-id pub-id-type="pmid">12783034</pub-id></element-citation></ref><ref id="CIT0019"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizza</surname><given-names>F.X</given-names></name><name><surname>Cavender</surname><given-names>D</given-names></name><name><surname>Stockard</surname><given-names>A</given-names></name><name><surname>Baylies</surname><given-names>H</given-names></name><name><surname>Beighle</surname><given-names>A</given-names></name></person-group><article-title>Anti-inflammatory doses of ibuprofen: effect on neutrophils and exercise-induced muscle injury</article-title><source>Int. J. Sports Med.</source><year>1999</year><volume>20</volume><fpage>98</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">10190769</pub-id></element-citation></ref><ref id="CIT0020"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powers</surname><given-names>S.K</given-names></name><name><surname>Jackson</surname><given-names>M.J</given-names></name></person-group><article-title>Exercise induced oxidative stress: cellular mechanisms and impact on muscle force production</article-title><source>Physiol. Rev.</source><year>2008</year><volume>88</volume><fpage>1243</fpage><lpage>1276</lpage><pub-id pub-id-type="pmid">18923182</pub-id></element-citation></ref><ref id="CIT0021"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quindry</surname><given-names>J</given-names></name><name><surname>Stone</surname><given-names>W</given-names></name><name><surname>King</surname><given-names>J</given-names></name><name><surname>Broeder</surname><given-names>C</given-names></name></person-group><article-title>The effects of acute exercise on neutrophils and plasma oxidative stress</article-title><source>Med. Sci. Sports Exerc.</source><year>2003</year><volume>35</volume><fpage>1145</fpage><lpage>1139</lpage></element-citation></ref><ref id="CIT0022"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revathi</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>A.K</given-names></name><name><surname>Soni</surname><given-names>L.K</given-names></name><name><surname>Kavitha</surname><given-names>S</given-names></name><name><surname>Wagh</surname><given-names>R</given-names></name><name><surname>Kaskhedikar</surname><given-names>S.G</given-names></name></person-group><article-title>Rationalization of physicochemical characters of 1,5-diarylpyrazole analogs as dual (COX-2/LOX-5) inhibitors: a QSAR approach</article-title><source>J. Pharm. Biomed. Anal.</source><year>2006</year><volume>42</volume><fpage>283</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">16781106</pub-id></element-citation></ref><ref id="CIT0023"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabia</surname><given-names>S</given-names></name><name><surname>Dugravot</surname><given-names>A</given-names></name><name><surname>Kivimaki</surname><given-names>M</given-names></name><name><surname>Brunner</surname><given-names>E</given-names></name><name><surname>Shipley</surname><given-names>M.J</given-names></name><name><surname>Singh-Manoux</surname><given-names>A</given-names></name></person-group><article-title>Effect of Intensity and Type of Physical Activity on Mortality: Results From the Whitehall II Cohort Study</article-title><source>Am. J. Public Health.</source><year>2011</year><volume>102</volume><fpage>698</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">21940933</pub-id></element-citation></ref><ref id="CIT0024"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinberg</surname><given-names>J</given-names></name><name><surname>Gainnier</surname><given-names>M</given-names></name><name><surname>Michel</surname><given-names>F</given-names></name><name><surname>Faucher</surname><given-names>M</given-names></name><name><surname>Arnaud</surname><given-names>C</given-names></name><name><surname>Jammes</surname><given-names>Y</given-names></name></person-group><article-title>The post-exercise oxidative stress is depressed by acetylsalicylic acid</article-title><source>Respir. Physiol. Neurobiol.</source><year>2002</year><volume>130</volume><fpage>189</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">12380009</pub-id></element-citation></ref><ref id="CIT0025"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tauler</surname><given-names>P</given-names></name><name><surname>Aguil&#x000f3;</surname><given-names>A</given-names></name><name><surname>Gimeno</surname><given-names>I</given-names></name><name><surname>Guix</surname><given-names>P</given-names></name><name><surname>Tur</surname><given-names>J</given-names></name><name><surname>Pons</surname><given-names>A</given-names></name></person-group><article-title>Different effects of exercise tests on the antioxidant enzyme activities in lymphocytes and neutrophils</article-title><source>J. Nutr. Biochem.</source><year>2004</year><volume>15</volume><fpage>479</fpage><lpage>484</lpage><pub-id pub-id-type="pmid">15302083</pub-id></element-citation></ref><ref id="CIT0026"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokmakidis</surname><given-names>S.P</given-names></name><name><surname>Kokkinidis</surname><given-names>E.A</given-names></name><name><surname>Smilios</surname><given-names>I</given-names></name><name><surname>Douda</surname><given-names>H</given-names></name></person-group><article-title>The effects of ibuprofen on delayed muscle soreness and muscular performance after eccentric exercise</article-title><source>J. Strength Cond. Res.</source><year>2003</year><volume>17</volume><fpage>53</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">12580656</pub-id></element-citation></ref><ref id="CIT0027"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>N. P</given-names></name><name><surname>Gleeson</surname><given-names>M</given-names></name><name><surname>Shephard</surname><given-names>R.J</given-names></name><name><surname>Woods</surname><given-names>J.A</given-names></name><name><surname>Bishop</surname><given-names>N.C</given-names></name><name><surname>Fleshner</surname><given-names>M</given-names></name><name><surname>Simon</surname><given-names>P</given-names></name></person-group><article-title>Position statement. Part one: Immune function and exercise</article-title><source>Exerc. Immunol. Rev.</source><year>2011</year><volume>17</volume><fpage>6</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">21446352</pub-id></element-citation></ref><ref id="CIT0028"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warden</surname><given-names>S.J</given-names></name></person-group><article-title>Cyclo-oxygenase-2 inhibitors: beneficial or detrimental for athletes with acute musculoskeletal injuries?</article-title><source>Sports Med.</source><year>2005</year><volume>35</volume><fpage>271</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">15831058</pub-id></element-citation></ref><ref id="CIT0029"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>S.P</given-names></name><name><surname>Deng</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>H.G</given-names></name><name><surname>Xu</surname><given-names>Z.M</given-names></name><name><surname>Dai</surname><given-names>H.Y</given-names></name><name><surname>Hong</surname><given-names>S.C</given-names></name><name><surname>Zhou</surname><given-names>H.N</given-names></name></person-group><article-title>Expression of COX-2 mRNA in peripheral blood monocytes from patients with acute myocardial infarction and its significance</article-title><source>Clin. Chem.</source><year>2005</year><volume>51</volume><fpage>2170</fpage><lpage>2173</lpage><pub-id pub-id-type="pmid">16244293</pub-id></element-citation></ref></ref-list></back></article>